The ability of ETA/BRA to contrast the induction of the M2 phenotype might contribute to attenuate ET-1 effects in those diseases characterized by extensive fibrosis and macrophage infiltrate, such as SSc. This evidence concerns the gene EDN1 and systemic sclerosis.